NP47827 Multiple Sclerosis Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

This public procurement record has 1 release in its history.

Planning

26 Oct 2026 at 16:53

Summary of the contracting process

The Common Services Agency, trading as Public Services Delivery Scotland (PSD Scotland), plans to establish a framework for multiple sclerosis medicines for NHS Scotland. The medicines under consideration are glatiramer acetate, interferon beta-1a, teriflunomide, dimethyl fumarate, fingolimod, natalizumab and cladribine tablets. The framework is intended to supply NHS Scotland bodies and Integrated Joint Boards across Scotland. The medicine range may change as the litigation landscape shifts. This is a medicines supply requirement, rather than a commission for clinical treatment or other healthcare services.

The process is at the planning stage: the buyer has announced an intention to procure, but has not yet invited tenders. A future notice is expected on 22 January 2027; this is an indicative publication date, not a bid deadline. The buyer plans a framework agreement covering a maximum combined initial and extension period of 48 months, with an estimated value of £30,403,887. It is divided into three product groupings: glatiramer acetate, interferon beta-1a and natalizumab; fingolimod, teriflunomide and dimethyl fumarate; and cladribine tablets. The first grouping is intended as an unranked multi-supplier framework by product line; the other two are intended as ranked multi-supplier frameworks by product line.

This is likely to suit pharmaceutical manufacturers and medicines wholesalers able to supply one or more of the named multiple sclerosis treatments to NHS Scotland. Suppliers should assess which product lines they can supply and whether they can support the scale and ongoing requirements of a multi-supplier framework. The first product grouping is planned without ranking suppliers, while the other groupings are planned to rank suppliers, so businesses should prepare for differing allocation arrangements across the products. The medicine list may change in response to litigation developments. The buyer has not yet set out detailed product specifications or volumes in this planning information; suppliers can use the expected next notice as a cue to prepare for the later tender stage.

How relevant is this notice?

Notice Information

Notice Title

NP47827 Multiple Sclerosis Medicines

Notice Description

The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine

Lot Information

Glatiramer acetate, Interferon beta-1a and Natalizumab

Supply of Glatiramer acetate, Interferon beta-1a and Natalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Cladribine tablets

Supply of cladribine tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Fingolimod, Teriflunomide and Dimethyl Fumarate

Supply of Fingolimod, Teriflunomide and Dimethyl Fumarate to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-079097
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/101240-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£30,403,887 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
26 Oct 2026Yesterday
Submission Deadline
Not specified
Future Notice Date
22 Jan 20273 months to go
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...